Zimmer Biomet Holdings ZBH
NYSE ZBH
$100.81 +0.07 (+0.07%)
At close: Aug 20, 2026 · 12:10 PM UTC

Zimmer Biomet Holdings (ZBH) Research & Development (2009 - 2026)

Zimmer Biomet Holdings (ZBH) posted quarterly Research & Development of $103.4 million for Q1 2026, down 6.51% year-over-year from $110.6 million in Q1 2025, and down 12.89% quarter-over-quarter from $118.7 million in Q4 2025.

Zimmer Biomet Holdings (ZBH) Research & Development (2009 - 2026) Analysis & Trends

Zimmer Biomet Holdings' Research & Development history runs 18 years deep, the most recent figure standing at $103.4 million for Q1 2026.

  • In Q1 2026, Research & Development fell 6.51% year-over-year to $103.4 million; the TTM figure through Mar 2026 stood at $451.3 million (up 2.54% YoY), while the FY2025 annual figure was $458.5 million, up 4.82% from the prior year.
  • Research & Development for Q1 2026 stood at $103.4 million, down from $118.7 million in the prior quarter.
  • The five-year high for Research & Development was $118.7 million in Q4 2025, with the low at $96.9 million in Q1 2022.
  • The 5-year median for Research & Development is $110.4 million (2023), against an average of $109.6 million.
  • Peak annual rise in Research & Development reached 19.63% in 2022, while the deepest fall reached 39.76% in 2022.
  • Zimmer Biomet Holdings' Research & Development stood at $108.0 million in 2022, then rose by 4.91% to $113.3 million in 2023, then decreased by 4.24% to $108.5 million in 2024, then grew by 9.4% to $118.7 million in 2025, then decreased by 12.89% to $103.4 million in 2026.
  • Business Quant data shows ZBH's Research & Development at $103.4 million in Q1 2026, $118.7 million in Q4 2025, and $115.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Abbott Laboratories 200.19 Bn 194.59 Bn 7.27 Bn 892.00 Mn
2 Stryker 129.95 Bn 126.47 Bn 4.50 Bn 434.00 Mn
3 Medtronic 120.06 Bn 110.84 Bn 6.41 Bn 671.00 Mn
4 Boston Scientific 74.14 Bn 73.60 Bn 3.85 Bn 554.00 Mn
5 Edwards Lifesciences 52.74 Bn 48.49 Bn 1.35 Bn 278.90 Mn
6 Dexcom 34.60 Bn 32.65 Bn 830.00 Mn 153.00 Mn
7 GE HealthCare Technologies 34.20 Bn 32.10 Bn 2.18 Bn 323.00 Mn
8 Koninklijke Philips 26.46 Bn 23.13 Bn 4.55 Bn -562.58 Mn
9 Steris 23.25 Bn 22.77 Bn 684.20 Mn 28.60 Mn
10 Zimmer Biomet Holdings 19.36 Bn 18.95 Bn 1.54 Bn 104.80 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 104.80 Mn
Mar 31, 2026 103.40 Mn
Dec 31, 2025 118.70 Mn
Sep 30, 2025 115.90 Mn
Jun 30, 2025 113.30 Mn
Mar 31, 2025 110.60 Mn
Dec 31, 2024 108.50 Mn
Sep 30, 2024 111.60 Mn
Jun 30, 2024 109.40 Mn
Mar 31, 2024 107.90 Mn
Dec 31, 2023 113.30 Mn
Sep 30, 2023 116.90 Mn
Jun 30, 2023 118.10 Mn
Mar 31, 2023 110.40 Mn
Dec 31, 2022 108.00 Mn
Sep 30, 2022 101.70 Mn
Jun 30, 2022 99.40 Mn
Mar 31, 2022 96.90 Mn
Dec 31, 2021 96.00 Mn
Sep 30, 2021 93.80 Mn